Síguenos en Twitter     Síguenos en Facebook     Síguenos en YouTube     Siguenos en Linkedin     Correo Grupsagessa     Gmail     Yahoo Mail     Dropbox     Instagram     Slack     Google Drive     Print     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon


Mi foto
FACP. Colegio de médicos de Tarragona Nº 4305520 / fgcapriles@gmail.com


Buscar en contenido


viernes, 16 de diciembre de 2011

Pro BNP and Heart Failure

Can NT-proBNP be used as a criterion for heart failure hospitalization
 in emergency room
Journal of Research in Medical Sciences, 2011; 16: 12
Ozturk TC et al. – NT-pro-brain natriuretic peptide can be used as an easy diagnostic method for congestive heart failure. A certain cut-off value may be determined in further multi-centre controlled trials with larger patient groups.
-This study was designed as a single-centre, prospective, and controlled trial.
-Blood samples and data were collected from a total of 119 patients with shortness of breath admitted to Emergency Department, School of Medicine, Marmara University.
-Patients were primarily diagnosed with decompensated heart failure according to the Framingham criteria and aged above 18years.
-A total of 92 patients were included in the study after exclusions.
-NT-proBNP measurements were made by immune fluorescent method.
-Available data were compared between hospitalized patients and outpatients.

-NT-proBNP levels were significantly higher in hospitalized patients compared to outpatients, and this finding was correlated with the clinical status of the patients.
-The mean NT-proBNP value of the patients was 9741.9±8973pg/ml (range: 245-35000) while the mean NT-proBNP value of patients diagnosed with non-decompensated CHF was 688.9±284.5pg/ml (range: 115-1450.65).